inner-banner-bg

Biomedical Science and Clinical Research(BSCR)

ISSN: 2835-7914 | DOI: 10.33140/BSCR

Impact Factor: 1.7

A Review on New Advancement in AIFA Guidelines

Abstract

Kaveri S. Gholap, Priyanka S. Pagar, Rushikesh L. Bachhav, Rutuja K. Deore, Khemchand R. Surana and Sunil K. Mahajan

Italy's pharmaceutical industry is governed and managed by the Italian Medicines Agency (AIFA). It publishes guidelines that offer thorough advice and rules for the creation, authorization, and post-marketing surveillance of pharmaceutical goods. These recommendations seek to promote patients' and healthcare providers' appropriate use of medications and medical equipment while also guaranteeing their efficacy, safety, and quality. Clinical trials, marketing authorization, pharmacovigilance, pricing, and reimbursement are only a few of the areas of pharmaceutical regulation that are covered by the AIFA standards. The recommendations seek to assure the availability of safe and effective medical products for the Italian people, foster innovation in the pharmaceutical business, and promote public health and safety by establishing defined standards and criteria.

PDF